Aradigm Corporation

Aradigm Corporation

Aradigm Corporation

Aradigm offer treatment for noncf bronchiectasis and nontb mycobacteria inhaled antibiotics patients with extensive drugs delivery in California, USA..
Raised
$23M
Follow us
Alexa global traffic share
Latest funding
$23,000,000
Debt financing - 2016
Team Size
10+
Employees

No recent coverage

Index constantly checks hot and trending companies for their latest activity. We haven't gotten to this company yet, but if you follow it you'll be the the first to know when Aradigm Corporation makes some noise.